Connection

DAVID G JOHNSON to Promoter Regions, Genetic

This is a "connection" page, showing publications DAVID G JOHNSON has written about Promoter Regions, Genetic.
Connection Strength

0.551
  1. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene. 1995 Nov 02; 11(9):1685-92.
    View in: PubMed
    Score: 0.080
  2. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 1994 Jul 01; 8(13):1514-25.
    View in: PubMed
    Score: 0.073
  3. Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif. Biochem Biophys Res Commun. 2014 Jan 24; 443(4):1239-44.
    View in: PubMed
    Score: 0.071
  4. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2011 Sep; 50(9):697-706.
    View in: PubMed
    Score: 0.059
  5. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene. 2006 Feb 09; 25(6):867-76.
    View in: PubMed
    Score: 0.041
  6. Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene. 2001 Aug 30; 20(38):5341-9.
    View in: PubMed
    Score: 0.030
  7. Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter. Genomics. 2001 May 01; 73(3):284-90.
    View in: PubMed
    Score: 0.029
  8. Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem. 2000 Feb 11; 275(6):4532-6.
    View in: PubMed
    Score: 0.027
  9. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nat Commun. 2018 09 13; 9(1):3707.
    View in: PubMed
    Score: 0.025
  10. Differential activities of E2F family members: unique functions in regulating transcription. Mol Carcinog. 1998 Jul; 22(3):190-8.
    View in: PubMed
    Score: 0.024
  11. Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression. Nat Commun. 2016 11 24; 7:13656.
    View in: PubMed
    Score: 0.022
  12. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro. J Immunol. 1992 Nov 15; 149(10):3225-31.
    View in: PubMed
    Score: 0.016
  13. Repression of androgen receptor transcription through the E2F1/DNMT1 axis. PLoS One. 2011; 6(9):e25187.
    View in: PubMed
    Score: 0.015
  14. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell. 2010 Sep 14; 18(3):220-30.
    View in: PubMed
    Score: 0.014
  15. The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes. Mol Cell Biol. 1990 Mar; 10(3):982-90.
    View in: PubMed
    Score: 0.014
  16. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.